Alpha-fetoprotein.
Despite all the information about AFP presented, a great deal still needs to be discovered especially in pregnancy. Geographical and racial differences remain to be elucidated. Similarly, differences in obstetric population in Helsinki and Baltimore, for example, are only now being studied. Sex differences may exist; Lardinois and associates195 cited a higher level of AFP in male than female fetuses. The important questions that need to be answered are whether AFP assays can help improve the other half of prenatal care- that directed to the fetus- and whether the AFP model can help enhance our understanding of the similarities and differences of fetal and cancer cells.
D000015:Abnormalities, Multiple / Q000196:embryology; D005260:Female; D005315:Fetal Diseases / Q000378:metabolism; D005326:Fetal Proteins; D006511:Hepatitis B Antigens; D006801:Humans; D008103:Liver Cirrhosis / Q000378:metabolism; D008107:Liver Diseases / Q000378:metabolism; D008297:Male; D009369:Neoplasms; D011247:Pregnancy; D011248:Pregnancy Complications / Q000378:metabolism; D011296:Prenatal Diagnosis; D011446:Prospective Studies; D000509:alpha-Fetoproteins / Q000032:analysis / Q000276:immunology / Q000502:physiology
D005326:Fetal Proteins; D006511:Hepatitis B Antigens; D000509:alpha-Fetoproteins